Recent advancement in daignosis of gastrointestinal diseases by Saraswat, Pranit et al.
8 
 
 
*For Correspondence: pranitsaraswat@gmail.com 
©2015 The authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY NC), which permits 
unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required 
from the authors or the publishers. 
                              Journal of Applied Pharmaceutical Research 2015, 3 (4): 08 – 13 
 
 
 
 
 
RECENT ADVANCEMENT IN DAIGNOSIS OF GASTROINTESTINAL DISEASES 
Pranit Saraswat*, Pragati Khare, Ritesh Kumar Tiwari 
Department of Pharmacy, Shri Ram Murti Smarak (C.E.T.), Bareilly, U.P., India  
 
Article Information  ABSTRACT 
Received: 09th September 2015  Gastrointestinal diseases refer to ulcerative disorders of the upper gastrointestinal tract. Stomach 
acids and some enzymes can damage the lining of the G.I. tract if natural protective factors are 
not functioning normally. Causes of gastrointestinal diseases are use of aspirin, alcohol and 
tobacco, poor diet (too many fried, fatty foods, sugar and refined foods), poor food combining, 
drinking with meals. Various diagnostic tests that can be performed for gastrointestinal diseases 
are Colonoscopy, ERCP, Flexible Sigmoidoscopy, Lower GI Series, Liver Biopsy, Upper GI 
Series, Upper Endoscopy. 
Revised: 23rd September 2015 
Accepted: 04th October 2015 
   
Keywords 
Sigmoidoscopy, liver biopsy, 
endoscopy, acid bile reflux 
 
 
INTRODUCTION 
Gastrointestinal tract: The tube that extends from the mouth 
to the anus in which the movement of muscles and release of 
hormones and enzymes digest food. The gastrointestinal tract 
starts with the mouth and proceeds to the esophagus, stomach, 
duodenum, small intestine, large intestine (colon), rectum and, 
finally, the anus. It is also called the alimentary canal, digestive 
tract and, perhaps most often in conversation, the GI tract. 
 
Fig. 1 Human Gastrointestinal (GI) Tract 
 
Gastrointestinal Diseases: Gastrointestinal diseases refer to 
ulcerative disorders of the upper gastrointestinal tract. Stomach 
acids and some enzymes can damage the lining of the G.I. tract 
if natural protective factors are not functioning normally. 
 
Symptoms of gastrointestinal diseases are indigestion, 
heartburn, nausea, loss of appetite, abdominal pain that is often 
worse after eating, and gastrointestinal bleeding (signs of this 
are vomiting material that looks like coffee-grounds, or having 
dark stools). Some other symptoms are acid bile reflux in the 
throat, asthma-like symptoms, often irritable bowel syndrome, 
and chronic poor digestion with sharp abdominal and chest 
pains, hoarseness and chronic cough. 
 
Causes of gastrointestinal diseases are use of aspirin, alcohol 
and tobacco, poor diet (too many fried, fatty foods, sugar and 
refined foods), poor food combining, drinking with meals, over 
eating especially spicy foods, eating too fast or too often, food 
allergies, candida overgrowth, stress, serious illness. Various 
pathogens, which usually get into our body through 
contaminated food and water, can produce an infection of the 
gastrointestinal tract. This manifests itself in diarrhea, often 
accompanied by pains in the stomach, nausea and vomiting. 
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Among the most frequent pathogens at fault are the E.coli 
bacteria, salmonella and poison from staphylococcus. 
Other causes of gastrointestinal disease may be reflux injury 
(such as bile backing up into the stomach and esophagus, 
trauma (for example surgery, radiation, chemotherapy, severe 
vomiting and having swallowed a foreign object), bacterial, 
viral, fungal and parasitic infections, pernicious anemia and 
systemic disease for example (Crohn's) disease. 
Gastrointestinal bleeding: Gastrointestinal bleeding refers to 
any bleeding that starts in the gastrointestinal tract, which 
extends from the mouth to the large bowel. The degree of 
bleeding can range from nearly undetectable to acute, massive, 
and life-threatening. 
Bleeding may come from any site along the gastrointestinal 
tract, but is often divided into: 
1. Upper GI bleeding: The upper gastrointestinal (GI) 
tract is located between the mouth and outflow tract of 
the stomach. 
2. Lower GI bleeding: The lower GI tract is located from 
the outflow tract of the stomach to the anus (small and 
large bowel included). 
Common Causes: Some of the possible causes of 
gastrointestinal bleeding include: 
 Haemorrhoids 
 Duodenal ulcer 
 Gastric (stomach) ulcer 
 Bleeding diverticulum 
 Ulcerative colitis 
 Crohn's disease 
 Oesophageal varices 
 Arterio-venous malformations 
 Nose bleed 
 Mallory-Weiss tear (tear in esophagus after vomiting) 
 Esophagitis 
 Dysentery (bloody, infectious diarrhoea) 
 Ischemic bowel 
 Colon cancer 
 Intestinal polyps 
 Celiac sprue 
 Radiation injury to the bowel 
 Portal hypertensive gastropathy 
 Stomach cancer 
 Intestinal vasculitis 
 Small intestinal cancer 
 Dieulafoy's lesion 
 Meckel's diverticulum 
 Aorto-enteric fistula 
 Cow's milk allergy 
 Intestinal obstruction (twisted bowel) 
 Intussusception (bowel telescoped on itself) 
 Anal fissure 
 
DIAGNOSTIC TESTS 
 Colonoscopy 
 ERCP 
 Flexible Sigmoidoscopy 
 Lower GI Series 
 Liver Biopsy 
 Upper GI Series 
 Upper Endoscopy 
 
Colonoscopy:  
Colonoscopy is the endoscopic examination of the colon and 
the distal part of the small bowel with a CCD camera or a fiber 
optic camera on a flexible tube passed through the anus. It may 
provide a visual diagnosis (e.g. ulceration, polyps) and grants 
the opportunity for biopsy or removal of suspected lesions. [1] 
Virtual colonoscopy, which uses 2D and 3D imagery 
reconstructed from computed tomography (CT) scans or from 
nuclear magnetic resonance (MR) scans, is also possible, as a 
totally non-invasive medical test, although it is not standard 
and still under investigation regarding its diagnostic abilities. 
Furthermore, virtual colonoscopy does not allow for 
therapeutic maneuvers such as polyp/ tumor removal or biopsy 
nor visualization of lesions smaller than 5 millimeters. If a 
growth or polyp is detected using CT colonography, a standard 
colonoscopy would still need to be performed. [2] Colonoscopy 
can remove polyps as small as one millimetre or less. Once 
polyps are removed, they can be studied with the aid of a 
microscope to determine if they are precancerous or not. 
Colonoscopy is similar to, but not the same as, sigmoidoscopy -
- the difference being related to which parts of the colon each 
can examine. A colonoscopy allows an examination of the 
entire colon (measuring four to five feet in length). A 
sigmoidoscopy allows an examination of only the final two feet 
of the colon. A sigmoidoscopy is often used as a screening 
procedure for a full colonoscopy -- done in many instances in 
conjunction with a fecal occult blood test (FOBT), which can 
detect the formation of cancerous cells throughout the colon. At 
other times, a sigmoidoscopy is preferred to a full colonoscopy 
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in patients having an active flare of ulcerative colitis or Crohn's 
disease to avoid a perforation of the colon. Additionally, 
surgeons have lately been using the term pouchoscopy to refer 
to a colonoscopy of the ileoanal pouch. 
 
Risks 
This procedure has a low (0.35%) risk of serious 
complications. [3] 
1. According to a study published in the Annals of Internal 
Medicine, for which researchers reviewed colon cancer 
screening data from 1966 to 2001 the most severe 
complications from colonoscopy are perforation (that 
occurred in 0.38% of cases), heavy bleeding (occurring in 
1.4% of colonoscopies) and death (occurring in 0.016% of 
colonoscopy patients).  
2. The most serious complication generally is the 
gastrointestinal perforation, which is life-threatening and 
requires immediate major surgery for repair. An analysis 
of the relative risks of sigmoidoscopy and colonoscopy, 
published in the February 5, 2003 issue of the Journal of 
the National Cancer Institute brought into attention that the 
risk of perforation after colonoscopy is approximately 
double that after sigmoidoscopy, even though this 
difference appeared to be decreasing.  
3. Bleeding complications may be treated immediately during 
the procedure by cauterization via the instrument. Delayed 
bleeding may also occur at the site of polyp removal up to 
a week after the procedure and a repeat procedure can then 
be performed to treat the bleeding site. Even more rarely, 
splenic rupture can occur after colonoscopy because of 
adhesions between the colon and the spleen. 
4. As with any procedure involving anaesthesia, other 
complications would include cardiopulmonary 
complications such as a temporary drop in blood pressure, 
and oxygen saturation usually the result of overmedication, 
and are easily reversed. Anesthesia can also increase the 
risk of developing blood clots and lead to pulmonary 
embolism or deep venous thrombosis (DVT).  In rare 
cases, more serious cardiopulmonary events such as a heart 
attack, stroke, or even death may occur; these are 
extremely rare except in critically ill patients with multiple 
risk factors. In very rare cases, coma associated with 
anesthesia may occur. Virtual colonoscopies carry risks 
that are associated with radiation exposure. 
5. Severe dehydration caused by the laxatives that are usually 
administered during the bowel preparation for colonoscopy 
also may occur. Therefore, patients must drink large 
amounts of fluids during the days of colonoscopy 
preparation to prevent dehydration. Loss of electrolytes or 
dehydration is potential risk that can even get deadly. In 
rare cases, severe dehydration can lead to kidney damage 
or renal dysfunction under the form of phosphate 
nephropathy.  
6. Colonoscopy preparation and colonoscopy procedure can 
cause inflammation of the bowels and diarrhea or even 
bowel obstruction. 
7. During colonoscopies where a polyp is removed (a 
polypectomy), the risk of complications has been higher, 
although still very uncommon, at about 2.3 percent. One of 
the most serious complications that may arise after 
colonoscopy is the postpolypectomy syndrome. This 
syndrome occurs due to potential burns to the bowel wall 
when the polyp is removed. It is however a very rare 
complication and as a result patients may experience fever 
and abdominal pain. The condition is treated with 
intravenous fluids and antibiotics while the patient is 
recommended to rest. 
8. Bowel infections are a potential colonoscopy risk, 
although very rare. The colon is not a sterile environment 
as many bacteria live in the colon to assure the well-
functioning of the bowel and therefore the risk of 
infections is very low. Infections can occur during biopsies 
when too much tissue is removed and bacteria protrude in 
areas they do not belong to or in cases when the lining of 
the colon is perforated and the bacteria get into the 
abdominal cavity. Infection may also be transmitted 
between patients if the colonoscope is not cleaned and 
sterilized properly between tests, although the risk of this 
happening is very low. [4] 
9. Minor colonoscopy risks may include nausea, vomiting or 
allergies to the sedatives that are used. If medication is 
given intravenously, the vein may become irritated. Most 
localized irritations to the vein leave a tender lump lasting 
a number of days but going away eventually. The 
incidence of these complications is less than 1%. 
10. On very rare occasions, intracolonic explosion may occur. 
Although complications after colonoscopy are uncommon, it is 
important for patients to recognize early signs of any possible 
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complications. They include severe abdominal pain, fevers and 
chills, or rectal bleeding (more than half a cup). 
 
Advantages 
1. Virtual colonoscopy does not require the insertion of a 
colonoscope into the entire length of the colon. Instead, a 
thin tube is inserted through the anus and into the rectum 
to expand the large intestine with air. 
2. No sedation is needed. A patient can return to usual 
activities or go home after the procedure without the aid of 
another person. 
3. Virtual colonoscopy provides clearer, more detailed 
images than a conventional X-ray using a barium enema—
sometimes called a lower GI series. 
4. Virtual colonoscopy takes less time than either 
conventional colonoscopy or a lower GI series. 
5. Virtual colonoscopy can see inside a colon that is 
narrowed due to inflammation or the presence of an 
abnormal growth. 
Disadvantages 
1. As with conventional colonoscopy, virtual colonoscopy 
requires bowel preparation and the insertion of a tube into 
the rectum for expanding the large intestine with gas or 
liquid. 
2. Virtual colonoscopy does not allow the doctor to remove 
tissue samples or polyps. 
3. Virtual colonoscopy does not detect pre-cancerous polyps 
smaller than 10 millimetres. 
4. Medicare and many health insurance plans do not pay for 
virtual colonoscopy cancer screening. 
5. Virtual colonoscopy is a newer technology and is not as 
widely available as conventional colonoscopy. 
 
ERCP (Endoscopic Retrograde cholangio 
pancreatography) 
It is a technique that combines the use of endoscopy and 
fluoroscopy to diagnose and treat certain problems of the 
biliary or pancreatic ductal systems. Through the endoscope, 
the physician can see the inside of the stomach and duodenum, 
and inject dyes into the ducts in the biliary tree and pancreas so 
they can be seen on X-rays. 
ERCP is used primarily to diagnose and treat conditions of the 
bile ducts, including gallstones, inflammatory strictures (scars), 
leaks (from trauma and surgery), and cancer. ERCP can be 
performed for diagnostic and therapeutic reasons, although the 
development of safer and relatively non-invasive investigations 
such as magnetic resonance cholangiopancreatography 
(MRCP) and endoscopic ultrasound has meant that ERCP is 
now rarely performed without therapeutic intent.[5] 
 
Risks 
1. The major risk of an ERCP is the development of 
pancreatitis, which can occur in up to 5% of all 
procedures. This may be self-limited and mild, but may 
require hospitalization, and rarely, may be life-
threatening. Patients at additional risk for pancreatitis are 
younger patients, patients with previous post-ERCP 
pancreatitis, females, procedures that involve cannulation 
or injection of the pancreatic duct, and patients with 
sphincter of Oddi dysfunction.[6] 
2. Gut perforation is a risk of any endoscopic procedure, 
and is an additional risk if a sphincterotomy is 
performed. As the second part of the duodenum is 
anatomically in a retroperitoneal location (that is, behind 
the peritoneal structures of the abdomen), perforations 
due to sphincterotomies are also retroperitoneal. 
Sphincterotomy is also associated with a risk of 
bleeding.[6] 
3. Over sedation can result in dangerously low blood 
pressure, respiratory depression, nausea, and vomiting. 
4. There is also a risk associated with the contrast dye in 
patients who are allergic to compounds containing 
iodine. 
 
LIVER BIOPSY 
Liver biopsy is the biopsy (removal of a small sample of tissue) 
from the liver. It is a medical test that is done to aid diagnosis 
of liver disease, to assess the severity of known liver disease, 
and to monitor the progress of treatment.[7] 
 
Types 
Liver biopsies may be taken 
1. Percutaneously (via a needle through the skin), 
2. Transvenously (through the blood vessels) or directly 
during abdominal surgery.  
The sample is examined by microscope, and may be processed 
further by immunohistochemistry, determination of iron and 
copper content, and microbiological culture if tuberculosis is 
suspected.[8] 
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Value and limitations 
1. For the last century liver biopsy has been considered as the 
gold standard for assessing the stage and the grade of 
chronic liver disease. Consensus conference statements 
recommended liver biopsy in the management of almost 
all patients with hepatitis C and B. 
2. Liver biopsy is generally a safe procedure, but it is 
invasive. Complications of liver biopsy are rare but 
potentially lethal. The majority of complications (60%) 
occur within two hours, and 96% occur within 24 hours 
following the procedure. Approximately 2-3% of patients 
undergoing liver biopsy require hospitalization for the 
management of an adverse event.[9] Thirty percent of 
patients experience significant pain during the procedure. 
Significant bleeding after a liver biopsy occurs in 1-2 out 
of 100 patients who are biopsied. Bleeding usually 
becomes apparent within three to four hours. It often stops 
on its own, but if it persists, a blood transfusion may be 
needed. Surgery or angiography (a procedure in which the 
bleeding site is identified and treated) may be required if 
the bleeding is severe or does not stop on its own. 
Intraperitoneal hemorrhage is the most serious 
consequence of bleeding. Fatal complications have been 
reported in up to 0.01-0.3% of biopsied patients.  
3. Biopsy results show significant variability (up to 40% for 
fibrosis diagnosis) which can lead to a wrong diagnosis. 
The result depends on the representatives of the punctured 
sample.  
4. The cost of liver biopsy is estimated at USD$1,032 
without complications and USD$2,745 with complications. 
5. Only 5% of patients at risk of fibrosis have liver biopsy. In 
2002, the consensus conferences in France and in the USA 
raised the possibility of treating patients with chronic 
hepatitis without liver biopsy.. These conferences also 
underlined the necessity of developing reliable non-
invasive tests that might be an alternative to liver biopsy 
both in hepatitis B and C. 
6. Liver biopsy will likely remain particularly important in 
the diagnosis of unexplained liver disease. Non-invasive 
tests for liver fibrosis in alcoholic, nonalcoholic and viral 
liver diseases are likely to become more widely used. 
 
UPPER GI SERIES 
An upper GI series uses X-rays to help diagnose problems of 
the upper GI tract, which includes the esophagus, stomach, and 
duodenum. The duodenum is the first part of the small 
intestine.  
 
Risks 
1. Mild constipation from the barium liquid is the most 
common complication of an upper GI series. Rarely, 
barium liquid causes bowel obstruction, a life-threatening 
condition that blocks the intestines. Drinking plenty of 
liquids after an upper GI series flushes out the barium and 
helps reduce the risks of constipation and bowel 
obstruction. 
2. Although infrequent, barium can cause an allergic reaction, 
which is treated with antihistamines. Some barium liquids 
contain flavours, which may also cause an allergic 
reaction. 
3. The risk of radiation-related damage to cells or tissues 
from an upper GI series is low. People who have recently 
undergone other X-ray tests should talk with their doctor 
about potential risks. 
Patients who experience any of the following rare symptoms 
should contact their doctor immediately: 
 Severe abdominal pain 
 Failure to have a bowel movement within 2 days after 
the procedure 
 Inability to pass gas 
 Fever 
 
UPPER GI ENDOSCOPY 
Upper GI endoscopy is a procedure that uses a lighted, flexible 
endoscope to see inside the upper GI tract. The upper GI tract 
includes the oesophagus, stomach, and duodenum—the first 
part of the small intestine. 
Upper GI endoscopy can detect: 
 Ulcers 
 Abnormal growths 
 Precancerous conditions 
 Bowel obstruction 
 Inflammation 
 Hiatal hernia 
 
Risks 
Risks associated with upper GI endoscopy include 
1. Abnormal reaction to sedatives 
2. Bleeding from biopsy 
3. Accidental puncture of the upper GI tract 
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Patients who experience any of the following rare symptoms 
after upper GI endoscopy should contact their doctor 
immediately: 
 Swallowing difficulties 
 Throat, chest, and abdominal pain that worsens 
 Vomiting 
 Bloody or very dark stool 
 Fever 
 
CONCLUSION 
Gastrointestinal diseases refer to ulcerative disorders of the 
upper gastrointestinal tract. Stomach acids and some enzymes 
can damage the lining of the G.I. tract if natural protective 
factors are not functioning normally. Symptoms of 
gastrointestinal disease are indigestion, heartburn, nausea, loss 
of appetite, abdominal pain that is often worse after eating, and 
gastrointestinal bleeding. 
 
Causes of gastrointestinal disease are aspirin use, alcohol and 
tobacco use, poor diet (to many fried, fatty foods, sugar and 
refined foods), poor food combining, drinking with meals, over 
eating especially spicy foods, eating too fast or too often, food 
allergies, candida overgrowth, stress, serious illness. Various 
pathogens, which usually get into our body through 
contaminated food and water, can produce an infection of the 
gastrointestinal tract. This manifests itself in diarrhea, often 
accompanied by pains in the stomach, nausea and vomiting. 
Among the most frequent pathogens at fault are the e-coli 
bacteria, salmonella and poison from staphylococcus.There are 
various diagnostic tests for gastrointestinal diseases such as 
Colonoscopy, ERCP, Flexible Sigmoidoscopy, Lower GI 
Series, Liver Biopsy, Upper GI Series and Upper Endoscopy. 
Prevention is better than treatment of any diseases.  
 
But in the cases of disease occur treatment is done in 2 steps 
first is Non clinical treatment by avoiding the various causes 
which are responsible for git diseases such as smoking, alcohol, 
NSAIDs and spicy food, irregular food and irregular sleep poor 
diet (to many fried, fatty foods, sugar and refined foods), poor 
food combining, drinking with meals, over eating especially 
spicy foods, eating too fast or too often, food allergies, candida 
overgrowth, stress, serious illness etc. second steps are clinical 
treatments by using medicines which are given by Doctors after 
complete diagnosis of patients.  
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